Oncolytics Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -16 | |||
EBITDA | -9,265 | -2,180 | -14,559 | -5,612 |
EBIT | -9,281 | -1,438 | -14,652 | -5,706 |
Net Income | -12,890 | -1,507 | -14,400 | -6,165 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,170 | -6,264 | -6,658 | -5,471 |
Cash | 5,493 | 5,202 | 12,352 | 14,626 |
Basic Shares | 112,292 | 95,857 | 101,315 | 90,999 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -298 | -301 | ||
EBITDA | -39,414 | -34,880 | -20,191 | -18,711 |
EBIT | -39,510 | -34,982 | -20,489 | -19,012 |
Net Income | -39,461 | -31,710 | -20,561 | -19,076 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,596 | -27,205 | -28,456 | -23,410 |
Cash | 7,137 | 15,942 | 34,912 | 11,666 |
Basic Shares | 95,857 | 76,483 | 67,624 | 58,029 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.11 |
2025-12-31 | $0 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.07 |